The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CONN, SRNE and CLNY

The Klein Law Firm


The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CONN, SRNE and CLNY

Monday, June 22, 2020 5:30 PM

NEW YORK, NY / ACCESSWIRE / June 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Conn's, Inc. (NASDAQ:CONN)
Class Period: September 3, 2019 - December 9, 2019
Lead Plaintiff Deadline: July 14, 2020

The CONN lawsuit alleges that throughout the class period, Conn's, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in CONN: http://www.kleinstocklaw.com/pslra-1/conns-inc-loss-submission-form?id=7475&from=1

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
Class Period: May 15, 2020 - May 22, 2020
Lead Plaintiff Deadline: July 27, 2020

During the class period, Sorrento Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in SRNE: http://www.kleinstocklaw.com/pslra-1/sorrento-therapeutics-inc-loss-submission-form?id=7475&from=1

Colony Capital, Inc. (NYSE:CLNY)
Class Period: August 9, 2019 - May 7, 2020
Lead Plaintiff Deadline: July 27, 2020

The complaint alleges Colony Capital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Colony's sale of its industrial real estate portfolio and the bifurcation of Colony Credit Real Estate's portfolio were foreseeably likely to negatively impact Colony's financial and operating results; (ii) certain of Colony's remaining portfolio companies carried unsustainable levels of debt secured by hotels and healthcare-related properties and were thus at a significant risk of default; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in CLNY: http://www.kleinstocklaw.com/pslra-1/colony-capital-inc-loss-submission-form?id=7475&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm


SHARE ARTICLE